Clinical Trial Update: Safety and Efficacy of Maraviroc in Post-stroke Cognitive Impairment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating safety and efficacy of maraviroc for post-stroke cognitive impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-stroke Cognitive Impairment

Drugs mentioned

• Maraviroc (maraviroc)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Post Stroke Cognitive Impairment | Phase 2 | Status: UNKNOWN